Sitagliptin SUN 25 mg film-coated tablets Patient Information Leaflet
To address this fear, clinicians should be knowledgeable about the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) study, which showed that insulin glargine 100 U/mL has a neutral effect on cardiovascular outcomes overall and a beneficial effect on microvascular complications, and the DEVOTE study, which established insulin degludec 100 U/mL as having a similar effect to insulin glargine 100 U/mL on the risk of cardiovascular events
c bit cn lu nu bn: Mc cc bnh nhim trng (HIV, st rt, bnh lao, vim gan C) Gp vn v tm thn (lo u, trm cm) ang iu tr cho hen suyn, d ng, ung th, ri lon cng dng, GERD, huyt p cao, cholesterol cao, bnh tim, au na u, bnh vy nn, vim khp dng thp, cc ri lon t min dch, hoc co git
In fact, many patients experience improved blood sugar control alongside weight loss